Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - riltozinameran, quantity: 50 microgram/ml; tozinameran, quantity: 50 microgram/ml - injection, suspension - excipient ingredients: water for injections; distearoylphosphatidylcholine; trometamol; trometamol hydrochloride; sucrose; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); cholesterol - comirnaty original/omicron ba.1 vaccine has provisional approval for the indication below: as a booster dose for active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 18 years of age and older. the use of this vaccine should be in accordance with official recommendations. the decision has been made on the basis of short term immunogenicity and safety data. continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tozinameran, quantity: 50 microgram/ml; famtozinameran, quantity: 50 microgram/ml - injection, suspension - excipient ingredients: cholesterol; sucrose; distearoylphosphatidylcholine; ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; trometamol hydrochloride; water for injections; trometamol - comirnaty original/omicron ba.4-5 vaccine has provisional approval for the indication below:,active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov- 2, in individuals12 years of age and older.,the use of this vaccine should be in accordance with official recommendations.,the decision has been made on the basis of short term immunogenicity and safety data. continued approval depends on the evidence of longer term efficacy and safety from ongoing clinical trials and post-market assessment.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - raxtozinameran, quantity: 16 microgram - injection, suspension - excipient ingredients: ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); water for injections; cholesterol; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; sucrose; distearoylphosphatidylcholine; trometamol; trometamol hydrochloride - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 5 years of age to less than 12 years of age.,the use of this vaccine should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - raxtozinameran, quantity: 225 microgram - injection, suspension - excipient ingredients: ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); water for injections; cholesterol; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; sucrose; distearoylphosphatidylcholine; trometamol; trometamol hydrochloride - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 12 years of age and older.,the use of this vaccine should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tozinameran, quantity: 40 microgram - injection, concentrated - excipient ingredients: ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); water for injections; cholesterol; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; sucrose; distearoylphosphatidylcholine; trometamol; trometamol hydrochloride - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 6 months of age to less than 5 years of age.,the use of this vaccine should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tozinameran, quantity: 225 microgram - injection, suspension - excipient ingredients: ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); water for injections; cholesterol; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; sucrose; distearoylphosphatidylcholine; trometamol; trometamol hydrochloride - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 12 years of age and older.,the use of this vaccine should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tozinameran, quantity: 130 microgram - injection, concentrated - excipient ingredients: ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); water for injections; cholesterol; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; sucrose; distearoylphosphatidylcholine; trometamol; trometamol hydrochloride - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 5 years of age to less than 12 years of age.,the use of this vaccine should be in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - tozinameran, quantity: 0.5 mg/ml - injection, concentrated - excipient ingredients: ((4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate); dibasic sodium phosphate dihydrate; water for injections; cholesterol; monobasic potassium phosphate; sodium chloride; potassium chloride; 2-((polyethylene glycol)-2000)-n-n-ditetradecylacetamide; sucrose; distearoylphosphatidylcholine - active immunisation to prevent coronavirus disease 2019 (covid-19) caused by sars-cov-2, in individuals 12 years of age and older.,the use of this vaccine should be in accordance with official recommendations.

Singapore - English - HSA (Health Sciences Authority)

biontech pharmaceuticals asia pacific pte. ltd. - raxtozinameran - injection - raxtozinameran 10 μg/dose

Singapore - English - HSA (Health Sciences Authority)

biontech pharmaceuticals asia pacific pte. ltd. - raxtozinameran - injection - raxtozinameran 30 μg/dose